Vasconcelles Michael

Vasconcelles Michael is listed in filings as Director at Kura Oncology, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including sale activity. Recent filings connect the profile to Kura Oncology, Inc. (KURA) and Day One Biopharmaceuticals, Inc. (DAWN). The current snapshot covers public activity from Sep 17, 2024 to Jun 4, 2026. Reported amounts are shown as $306.9K to $1.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.